Skip to main content
Download PDF

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

Pilot and Feasibility Studies volume 2, Article number: 55 (2016) Cite this article

The Original Article was published on 01 February 2016

Erratum

After publication of the original article [1], it came to the authors’ attention that a source of funding had been inadvertently omitted from the Acknowledgements section; support from Yorkshire Cancer Research should have mentioned originally.

Reference

  1. Snee MP, McParland L, Collinson F, Lowe CM, Striha A, Baldwin DR, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot Feasability Studies. 2016;2:5. doi:10.1186/s40814-016-0046-2.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF, UK

    M. P. Snee, D. Sebag-Montefiore & K. N. Franks

  2. Clinical Trials Research Unit (CTRU), Leeds Institute of Clinical Trials Research, University of Leeds, 71-75 Clarendon Road, Leeds, LS2 9PH, UK

    L. McParland, F. Collinson, C. M. Lowe, A. Striha, W. M. Gregory & S. Hinsley

  3. Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals and University of Nottingham, Hucknall Rd, Nottingham, NG5 1PB, UK

    D. R. Baldwin

  4. School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, Edgbaston B15 2TT, UK

    B. Naidu

  5. Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, 101 Clarendon Rd, Leeds, LS2 9LJ, UK

    J. Bestall & J. Hewison

  6. Leeds Institute of Cancer and Pathology, Faculty of Medicine and Health, University of Leeds, Beckett Street, Leeds, LS9 7TF, UK

    D. Sebag-Montefiore

Authors
  1. M. P. Snee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. McParland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Collinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. M. Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Striha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. R. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Naidu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Sebag-Montefiore
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. M. Gregory
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. Bestall
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J. Hewison
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S. Hinsley
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K. N. Franks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. N. Franks.

Additional information

The online version of the original article can be found under doi:10.1186/s40814-016-0046-2.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Snee, M.P., McParland, L., Collinson, F. et al. Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot Feasibility Stud 2, 55 (2016). https://doi.org/10.1186/s40814-016-0095-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40814-016-0095-6

Pilot and Feasibility Studies

ISSN: 2055-5784